Augnito vs Speke (2026)
Two ambient products from companies that were doing this work with people and dictation long before models could. Augnito comes from a transcription business with more than two decades in a national health service estate, and it pairs clinical speech recognition with ambient documentation in one platform, which suits an organisation migrating clinicians from dictation rather than starting fresh. Speke comes from the largest human medical scribe company in the United States, with over a thousand clients behind it, so its automation spectrum runs from a fully drafted note to a human scribe without changing supplier. Neither publishes an accuracy figure. The real question for both is the same one their pure play competitors never have to answer: as the automated tier absorbs more of the volume, what happens to the humans in the service and to the price you were quoted.
- Two decades of clinical speech work behind it, with deep experience in a national health service estate, which is a different operating environment from United States ambulatory practice.
- Speech recognition and ambient documentation in one platform, so an organisation moving clinicians from dictation to ambient capture does not change vendor midway.
- For non United States deployments, the regulatory and procurement experience is already in the company rather than being acquired on your project.
- It comes from the largest human medical scribe company in the United States, serving over a thousand clients, which is an installed base no pure play can match.
- The human tier is the company's core business rather than an option, so a practice can move along the automation spectrum without changing supplier.
- For a health system already using scribe services, this is continuity rather than a new vendor relationship and a new security review.
This comparison is published by AI Health Index, an independent research platform that compares healthcare AI vendors objectively. Augnito and Speke are each graded against the same capability taxonomy, from each vendor's own public materials and the regulatory record, under the AI Health Index verification standard. No vendor pays for placement, and no vendor has reviewed this page. How this evidence is graded
Plain facts
| Fact | Augnito | Speke |
|---|---|---|
| Primary category | Ambient Scribes | Ambient Scribes |
| Founded | 2020 | Not recorded |
| Headquarters | United Kingdom and India | Fort Lauderdale, Florida, United States |
| Website | augnito.ai | spekeai.com |
Side by Side
Each record in one paragraph
Written to be quoted whole. Each paragraph states what the AI Health Index verified about the vendor, with the caveats attached. Generated from this pair’s live capability grades, so it moves when a grade moves.
The AI Health Index awards Augnito its top capability grade on AI Centrality and Setting and Specialty Coverage. Set against Speke, Augnito grades higher on FDA and Regulatory Status. Its thinnest published disclosure sits on AI Liability and Recourse. Grades reflect evidence the AI Health Index could verify at the last review, so a low grade records disclosure the vendor has not published rather than a capability it has been shown to lack.
Source: AI Health Index, August 2026
The AI Health Index awards Speke its top capability grade on AI Centrality and Setting and Specialty Coverage. Set against Augnito, Speke grades higher on several axes, including Autonomy and Oversight Model, Clinical and Operational Evidence and Security Certifications and Trust Center. Grades reflect evidence the AI Health Index could verify at the last review, so a low grade records disclosure the vendor has not published rather than a capability it has been shown to lack.
Source: AI Health Index, August 2026
Questions buyers ask
Should we choose Augnito or Speke?
On the axes where the AI Health Index separates them, Augnito grades higher on FDA and Regulatory Status, and Speke grades higher on several axes, including Autonomy and Oversight Model, Clinical and Operational Evidence and Security Certifications and Trust Center. Speke leads on the greater share of scored axes, but the split means the decision turns on which constraint is binding rather than on an overall winner.
Where do Augnito and Speke differ most?
The widest separation the AI Health Index records between Augnito and Speke is on FDA and Regulatory Status, where Augnito grades B and Speke grades C. That axis sits in the Regulatory and Compliance group, so it should carry the most weight for a buyer whose binding constraint is where regulatory exposure sits and who carries it.
Where do Augnito and Speke grade the same?
The AI Health Index grades Augnito and Speke the same on several axes, including AI Centrality, Model and Technology Transparency and Model Supply Chain Disclosure. Neither holds an advantage the index can evidence on those axes, so they should not carry weight in a selection between these two.
What have Augnito and Speke not disclosed?
At the last review, at least one of Augnito and Speke published thin or absent detail on AI Liability and Recourse. The AI Health Index treats an absent disclosure as a gap in the public record rather than a failure of the product, so these are the axes to get in writing during diligence instead of inferring from the grade.
Related comparisons
Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the Ambient Scribes page.
Both vendors carry a legacy services business alongside the AI product, so the commercial comparison is not like for like against a per clinician software subscription and depends on the mix of automated and human reviewed work. Neither publishes an accuracy figure, model card or evaluation methodology. Neither publishes a rate card.
For any deployment outside the United States, establish which regime governs the product in that market rather than assuming the United States position transfers, and for any deployment inside it, ask what the service level looks like when the automated tier cannot produce an acceptable note.